Literature DB >> 17872461

Sphingosine 1-phosphate receptor 2 negatively regulates neointimal formation in mouse arteries.

Takuya Shimizu1, Tatsu Nakazawa, Aesim Cho, Frank Dastvan, Dustin Shilling, Günter Daum, Michael A Reidy.   

Abstract

Neointimal lesion formation was induced in sphingosine 1-phosphate (S1P) receptor 2 (S1P2)-null and wild-type mice by ligation of the left carotid artery. After 28 days, large neointimal lesions developed in S1P2-null but not in wild-type arteries. This was accompanied with a significant increase in both medial and intimal smooth muscle cell (SMC) replication between days 4 to 28, with only minimal replication in wild-type arteries. S1P2-null SMCs showed a significant increase in migration when stimulated with S1P alone and together with platelet-derived growth factor, whereas both wild-type and null SMCs migrated equally well to platelet-derived growth factor. S1P increased Rho activation in wild-type but not in S1P2-null SMCs, and inhibition of Rho activity promoted S1P-induced SMC migration. Plasma S1P levels were similar and did not change after surgery. These results suggest that activation of S1P2 normally acts to suppress SMC growth in arteries and that S1P is a regulator of neointimal development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17872461     DOI: 10.1161/CIRCRESAHA.107.159228

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  25 in total

Review 1.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

2.  Sphingosine-1-phosphate receptor 3 promotes neointimal hyperplasia in mouse iliac-femoral arteries.

Authors:  Takuya Shimizu; Allison De Wispelaere; Martin Winkler; Travis D'Souza; Jacob Caylor; Lihua Chen; Frank Dastvan; Jessie Deou; Aesim Cho; Axel Larena-Avellaneda; Michael Reidy; Guenter Daum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-02-02       Impact factor: 8.311

Review 3.  Regulation of vascular physiology and pathology by the S1P2 receptor subtype.

Authors:  Athanasia Skoura; Timothy Hla
Journal:  Cardiovasc Res       Date:  2009-03-15       Impact factor: 10.787

4.  Engineering vascularized tissues using natural and synthetic small molecules.

Authors:  Lauren S Sefcik; Caren E Petrie Aronin; Edward A Botchwey
Journal:  Organogenesis       Date:  2008-10       Impact factor: 2.500

Review 5.  Signaling mechanisms that regulate smooth muscle cell differentiation.

Authors:  Christopher P Mack
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07       Impact factor: 8.311

6.  DJ-1 is involved in epigenetic control of sphingosine-1-phosphate receptor expression in vascular neointima formation.

Authors:  Kang Pa Lee; Suji Baek; Seung Hyo Jung; Long Cui; Donghyen Lee; Dong-Youb Lee; Wahn Soo Choi; Hyun Woo Chung; Byeong Han Lee; Bokyung Kim; Kyung Jong Won
Journal:  Pflugers Arch       Date:  2018-03-06       Impact factor: 3.657

7.  Sphingosine-1-phosphate receptor-2 regulates expression of smooth muscle alpha-actin after arterial injury.

Authors:  Allison D Grabski; Takuya Shimizu; Jessie Deou; William M Mahoney; Michael A Reidy; Guenter Daum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-16       Impact factor: 8.311

Review 8.  The vascular S1P gradient-cellular sources and biological significance.

Authors:  Timothy Hla; Krishnan Venkataraman; Jason Michaud
Journal:  Biochim Biophys Acta       Date:  2008-07-28

9.  Integrative genomics identifies DSCR1 (RCAN1) as a novel NFAT-dependent mediator of phenotypic modulation in vascular smooth muscle cells.

Authors:  Monica Y Lee; Sean M Garvey; Alex S Baras; Julia A Lemmon; Maria F Gomez; Pamela D Schoppee Bortz; Guenter Daum; Renee C LeBoeuf; Brian R Wamhoff
Journal:  Hum Mol Genet       Date:  2009-11-19       Impact factor: 6.150

Review 10.  Sphingosine-1-phosphate receptor 2.

Authors:  Mohamad Adada; Daniel Canals; Yusuf A Hannun; Lina M Obeid
Journal:  FEBS J       Date:  2013-08-19       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.